Peg-intron and Lorcet-hd drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Peg-intron (peginterferon alfa-2b) and Lorcet-hd (acetaminophen; hydrocodone bitartrate). Common drug interactions include dysphagia among females.

The phase IV clinical study analyzes what interactions people have when they take Peg-intron and Lorcet-hd. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users. Check the latest studies of Peg-intron.

What is Lorcet-hd?

Lorcet-hd has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 2,221 Lorcet-hd users. Check the latest studies of Lorcet-hd.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

14 people who take Peg-intron and Lorcet-hd together, and have interactions are studied.

Peg-intron and Lorcet-hd drug interactions.

What are the common drug interactions of Peg-Intron and Lorcet-Hd, by gender? *:

female:

Dysphagia (a condition in which swallowing is difficult or painful)
Alopecia (absence of hair from areas of the body)
Injection site rash
Injection site reaction
White blood cell count decreased
Arthralgia (joint pain)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Nausea (feeling of having an urge to vomit)
Oedema peripheral (superficial swelling)
Stomatitis (inflammation of mucous membrane of mouth)

male:

n/a

What are the common drug interactions of Peg-Intron and Lorcet-Hd, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Bacterial infection
Cellulitis (infection under the skin)
Constipation
Cough
Crying
Culture wound positive
Dysphagia (a condition in which swallowing is difficult or painful)
Epidermal necrosis (skin condition that is usually caused by a reaction to drugs)
Impaired healing

40-49:

Arthralgia (joint pain)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Intervertebral disc protrusion (spinal disc protrusion)
Muscular weakness (muscle weakness)
Nerve root compression
Oedema peripheral (superficial swelling)
Radial nerve palsy (paralysis of radial nerve)
Spinal column stenosis (narrowing of spinal column)
Spinal osteoarthritis (joint cartilage loss in spine)
Alopecia (absence of hair from areas of the body)

50-59:

Alopecia (absence of hair from areas of the body)
Dehydration (dryness resulting from the removal of water)
Anger
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Injection site erythema (redness at injection site)
Nausea (feeling of having an urge to vomit)
Throat tightness
Vomiting
Burning sensation
Drug hypersensitivity

60+:

n/a

What are the existing conditions these people have? *

Hepatitis C: 12 people, 85.71%
Hepatitis (inflammation of the liver): 2 people, 14.29%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Peg-intron and Lorcet-hd?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously